<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26633119</identifier>
<setSpec>0717-6341</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Guerrero, Carmelo</dc:author>
<dc:author>Burgués, Pedro</dc:author>
<dc:author>Ruíz del Olmo, Ignacio</dc:author>
<dc:author>Romera, Beatriz</dc:author>
<dc:author>Bustillo, Matilde</dc:author>
<dc:description xml:lang="en">Non-tuberculous mycobacterial adenitis is getting more common in our environment. Epidemiologic studies and clinical trials published nowadays are limited. We present a 2-years-old boy diagnosed of Mycobacterium intracellulare adenitis and severe neutropenia as side effect of combined treatment with oral azythromycin and rifabutin, which recovers after suspending the second one. Liver metabolism of macrolide seems to increase other drugs toxicity, in this case, rifabutin. The patient eventually needed surgery due to persistence of the adenitis despite treatment with antibiotics.</dc:description>
<dc:type>Case Reports</dc:type>
<dc:language>es</dc:language>
<dc:date>2015 Oct </dc:date>
<dc:title xml:lang="es">Neutropenia grave secundaria al tratamiento médico de una adenitis por micobacterias no tuberculosas.</dc:title>
<dc:title xml:lang="en">[Severe neutropenia as side effect of medical treatment in nontuberculous mycobacterial adenitis].</dc:title>
<dc:publisher>Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia</dc:publisher>
</metadata>
</record>
</pubmed-document>
